Prostate Cancer - Results from #200

Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review. March 31, 2022

Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer. March 31, 2022

Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer. March 31, 2022

Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer. March 30, 2022

Absolute PSA after 6 Months of Androgen Deprivation Therapy is a Predictor of Overall and Cancer Specific Mortality in Men with Hormone-Sensitive Prostate Cancer. March 30, 2022

Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: A multiparametric MRI study according to PI-RADS version 2.1. March 30, 2022

Androgen-deprivation therapy and cognitive decline in the NEON-PC prospective study during the COVID-19 pandemic. March 30, 2022

A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men. March 30, 2022

Cumulative Burden of Psychiatric Disorders and Self-Harm Across 26 Adult Cancers March 29, 2022

Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development March 29, 2022

Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression. March 29, 2022

Comparative Effectiveness of Abiraterone and Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer in Taiwan. March 29, 2022

Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology. March 29, 2022

Retrospective analysis of MV-kV imaging-based fiducial tracking in prostate SBRT treatment. March 29, 2022

Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial. March 29, 2022

Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study. March 28, 2022

Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer. March 28, 2022

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. March 28, 2022

Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States. March 28, 2022

Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer. March 28, 2022

Page 11 of 1223

email news signup